vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Inc. (VTVT) is a healthcare company (biotechnology) based in the United States. The share price is $16.71, down 5.54% on the day, which values the company at $67.04M. Price as of 17 Nov 2026, 20:30 UTC, from Yahoo Finance.

Key facts

Share price
$16.71−5.54% today
Market value
$67.04M
200-week average
$23.4029% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

vTv Therapeutics Inc. in more detail

VTVT trades at -4.3× next year's expected earnings, 1.8× sales. It sits 29% below its 200-week average of $23.40.

Worth checking: Share count keeps rising; Thin interest cover.

1 of the superinvestors tracked here hold VTVT, including Julian and Felix Baker (0.0% of the portfolio).

Superinvestors holding VTVT

1 of the investors tracked here report a position in their latest 13F filing.

vTv Therapeutics Inc. (VTVT): questions and answers

What is vTv Therapeutics Inc.'s market cap?

vTv Therapeutics Inc. is valued at $67.04M at a share price of $16.71.

Is VTVT above its 200-week moving average?

No. VTVT is 28.6% below its 200-week average of $23.40. Long-term investors watch that line because strong companies rarely trade below it for long.

Does VTVT pay a dividend?

vTv Therapeutics Inc. does not currently pay a regular dividend.

Which famous investors own VTVT?

In their latest quarterly filings, Julian and Felix Baker (0.0% of the portfolio) hold VTVT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “vTv Therapeutics Inc. (VTVT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/VTVT

Underlying data: Yahoo Finance; company filings with the SEC.